Navigation Links

Biology Technology

Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets

10/20/2014
(PRWEB) October 20, 2014 The report “Pharmacy Automation Systems Market by product type (Medication Dispensing Systems, Packaging and Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy Automation, Outpatient Pharmacy Automation) - Global Forecasts & Trends to 2019” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, A... [Comments]

Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production

10/20/2014
NEW YORK , Oct. 20, 2014 Mapp Biopharmaceutical's valiant effort to produce more of their experimental ZMapp™ antibody therapeutic to fight the Ebola outbreak will make the public aware of how difficult and time-consuming the production of pharmaceuticals can be, according to Kalorama Information.  The healthcare market research publisher said that while some may be... [Comments]

Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex

10/20/2014
Richardson, Texas (PRWEB) October 20, 2014 Convey Computer , the leader in hybrid-core computing, today announced that a team from Iowa State University won first place in the 2014 MemoCODE Conference * design contest. Using a Convey HC-2ex, the team’s solution achieved the highest overall performance in the contest—more than 14 times faster than the second place finisher. Experts from... [Comments]

Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury

10/20/2014
MENLO PARK, Calif. , Oct. 20, 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: AST) announced today that the Company has signed a Notice of Grant Award (NGA) with the California Institute of Regenerative Medicine (CIRM), effective October 1, 2014.  The NGA provides for the immediate release of Clinical Development payments and the release of additional grant funds pursuant... [Comments]

BIOREM announces additional orders for $1.7 million

10/20/2014
GUELPH, ON , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced four new orders totalling $1.7 million which brings Q3 orders to $5.8 million and provides a good start to Q4.  The orders are for three odour control projects in North America and one in the Middle East . "We continue to bid new projects at record levels," said Peter B... [Comments]

Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe

10/20/2014
VIENNA , October 20, 2014 A major pan-European survey into the burden of gastrointestinal (GI) disorders and the delivery of care has revealed changing trends in many important GI and liver diseases and worrying inequalities in the provision of healthcare services across the continent. The results of the survey, which was commissioned by United European Gastroenterology (U... [Comments]

Zola P. Horovitz To Retire From GenVec Board

10/20/2014
GAITHERSBURG, Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: GNVC ) today announced the retirement of Zola P. Horovitz , Ph.D., from its board of directors effective on October 24, 2014.   Dr. Horovitz joined the GenVec board in August 2003, and served as its chairman from June 2006 to November 2013.  During his tenure, he also served on the Nominating and Co... [Comments]

PureTech Announces Expansion with Oversubscribed $55M Funding Round

10/20/2014
BOSTON , Oct. 20, 2014 PureTech , a science and technology development and commercialization company tackling big healthcare problems, announced today the closing of a $55 million growth stage investment round, with participation from Invesco Perpetual, a $120 Billion group of funds. The funding will be used to drive PureTech's existing pipeline forward and to advance ne... [Comments]

Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive

10/20/2014
PLAINSBORO, N.J. (PRWEB) October 20, 2014 OncLive® is pleased to announce that the Sidney Kimmel Cancer Center at Thomas Jefferson University has joined its Strategic Alliance Partnership program. Through the Strategic Alliance Partnership program, the Sidney Kimmel Cancer Center at Jefferson and OncLive will collaborate to raise awareness of the Center’s cutting-edge research pr... [Comments]

NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice

10/20/2014
Rochelle, Virginia (PRWEB) October 20, 2014 Earle Martin , Chief Executive Officer of NDA Partners LLC, announced today that Ellen Teplitzky, an experienced attorney specializing in business matters and legal support for the pharmaceutical industry, has joined the firm as Director of Legal Services and manager of its legal services practice. NDA Partners provides legal services, including... [Comments]

Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis

10/20/2014
Tigard, OR (PRWEB) October 20, 2014 Local veterinary surgeon, Dr. Tim McCarthy is seeking candidates to participate in an investigational study of donor stem cells for dogs with osteoarthritis. Dr. McCarthy has lectured nationally in stem cell therapy and has performed clinical stem cell therapy for 7 years. The ultimate goal of this study is to determine if a single injection of donor stem... [Comments]

Medicine Technology

PneumRx Completes RENEW Pivotal Trial Enrollment

10/20/2014
MOUNTAIN VIEW, Calif. , Oct. 20, 2014  PneumRx, Inc. ( www.pneumrx.com ), a leader in the field of interventional pulmonology, today announced completion of enrollment in their RENEW Study, nearly 3 months ahead of schedule.  The RENEW Clinical Study is the FDA-approved IDE pivotal trial for the PneumRx RePneu Coil System, a treatment for severe emphysema. It was an... [Comments]

PneumRx concluye inscripción en prueba fundamental RENEW

10/20/2014
MOUNTAIN VIEW, California , 20 de octubre de 2014  PneumRx, Inc. ( www.pneumrx.com ), un líder en el campo de la pulmonología intervencional, anunció hoy la conclusión de la inscripción en su Estudio RENEW, casi 3 meses antes de lo programado. El Estudio Clínico RENEW es la prueba fundamental de exención de dispositivo de investigaci... [Comments]

Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery

10/20/2014
BOSTON , Oct. 20, 2014  Indianapolis interventional medical device maker NICO Corporation and Toronto -based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery. The collaboration is the first of its kind and will ma... [Comments]

Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences

10/20/2014
ENGLEWOOD, Colo. , Oct. 20, 2014  Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), today announced that its academic collaborators will present several peer-reviewed posters highlighting the clinical and research potential for its novel RedoxSYS Diagnostic System, a first-in-class platform that measures oxidation-reduction potential (... [Comments]

ResMed Launches ResMed Data Exchange

10/20/2014
SAN DIEGO , Oct. 20, 2014  ResMed (NYSE: RMD ) today announced the availability of the ResMed Data Exchange program, a comprehensive suite of software and service solutions for home medical equipment (HME) and other health care providers. ResMed Data Exchange offers timely, secure access to critical patient information. It integrates valuable sleep and respiratory tre... [Comments]

Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award

10/20/2014
BRIDGEWATER, N.J. , Oct. 20, 2014 Valeritas, Inc., a leader in simple, disposable basal-bolus insulin delivery technology designed for patients with Type 2 diabetes, announced today that it has received a 2014 Cardinal Health Supply Chain Excellence Award. The award was presented October 16 th at Cardinal's annual Business Partners Conference in Columbus, Ohio . The Car... [Comments]

BioNano Genomics Announces One Human : One Chip : One Day

10/20/2014
SAN DIEGO , Oct. 20, 2014   BioNano Genomics announced today achievement of a major milestone for the Irys system: the ability to collect human data at 30X depth, sufficient for a genome map, in 24 hours on a single chip.  This new capability was established and demonstrated for the IrysChip TM V2, the high-throughput chip for the Irys TM System and will be rolle... [Comments]

AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement

10/20/2014
SAN DIEGO , Oct. 20, 2014  AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Marco Londei , M.D. as Chief Development Officer. Dr. Londei will lead the preclinical and clinical development of AnaptysBio's proprietary antibody pipeline.  "We are pleased to welcome Dr. Londei to AnaptysBio's exe... [Comments]

Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer

10/20/2014
PRINCETON, N.J. , Oct. 20, 2014   Taiho Oncology, Inc. , a subsidiary of Taiho Pharmaceutical Co., Ltd. ( Japan ), announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug under investigation for the treatment of refractory me... [Comments]

Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs

10/20/2014
SAN DIEGO , Oct. 20, 2014 Lpath, Inc. (NASDAQ: LPTN ), the industry leader in bioactive lipid-targeted therapeutics, received official notification from the European Patent Office that the company has been granted another key patent supporting its iSONEP™ and ASONEP™ programs. This newly issued patent, European patent No. 2087002, claims compositions of m... [Comments]

Pharmaceutic Labs Opens CGMP Outsourcing Facility in Albany, NY

10/20/2014
ALBANY, N.Y. , Oct. 20, 2014 Pharmaceutic Labs announces the opening of its specialty CGMP pharmaceutical outsourcing facility in Albany, NY for admixing, compounding, drug shortages and clinical studies and trials. The company meets and/or exceeds the FDA standards for safety and quality, using 21 CFR Part 210 and 21 CFR Part 211. The 10,000 square foot outsourcing fac... [Comments]

(Date:10/19/2014)... 19, 2014 The report "Chocolate, Cocoa ... Trade, Prices, Geography Trend and Forecast (2011 - 2016)," ... and geography and studies the major market drivers, restraints, ... Europe, and Asia. , The global chocolate market is ... billion in 2016 at an estimated CAGR of 2.7% ...
(Date:10/19/2014)... According to market research report “Outdoor Wi-Fi Market ... Global Advancements, Forecasts and Analysis (2013 - 2018)", ... with analysis and forecasting of the global revenues. ... and the restrains for this market with the ... Browse 65 market data tables and 69 figures ...
(Date:10/18/2014)... (PRWEB) October 18, 2014 The ... - Trends and Forecasts to 2019", analyzes the ... in order to understand the industry details such ... opportunities across various geographic regions. , Browse 81 ... 202 Slides and in-depth TOC on “1,6-Hexanediol Market ...
(Date:10/18/2014)... The Asia-Pacific Liquid Crystal on Silicon (LCoS) display ... Asia-Pacific with analysis and forecast of revenue. This market ... expected to reach $380.0 million by 2018, at a ... through the TOC of the Asia-Pacific LCoS display market ... provided. This also provides a glimpse of the segmentation ...
Breaking Biology Technology:Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 2Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 3Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 41,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 21,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 31,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 41,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 5The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor 3
... ... HPCwire,s Readers, Choice Award for Best Application of Green Computing. The award was ... ongoing in Portland, Ore. , ... Portland, OR (Vocus) Nov. 17, 2009 --- The U.S. Department of Energy,s ...
... Pharma guarantees to purchase 50,000 KINLYTIC vials over next ... Biosystems Inc. (MBX:TSX), a biotech company focused on virology ... agreement with Riso Pharma that guarantees purchases of not ... years. KINLYTIC (Urokinase) is Microbix, thrombolytic agent for treating ...
... , ROCKVILLE, Md., Nov. 17 Neuralstem, Inc. (NYSE Amex: ... the third quarter ended September 30, 2009. , (Logo: ... of 2009, the Company reported a net loss of $5,096,983, or ... $0.10 per share, for the comparable 2008 period. The increase was ...
Cached Biology Technology:Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 2Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 3Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 4Microbix Signs Marketing Agreement For Kinlytic(R)(Urokinase) In Growing Middle East Region 2Microbix Signs Marketing Agreement For Kinlytic(R)(Urokinase) In Growing Middle East Region 3Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update 2Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update 3Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update 4Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update 5Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update 6Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update 7
(Date:10/19/2014)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the ... to office-based dental, animal health and medical practitioners, announced ... Inc., a leading full-service provider of dental consumables, implants ... into Japan , the world,s 2 ... the number of countries in which the Company operates. ...
(Date:10/18/2014)... 18, 2014  In a policy paper ... the nation,s largest lesbian, gay, bisexual and transgender ... of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is ... prevent the spread of a disease or infection ... name anti-HIV drug combination currently approved for PrEP, ...
(Date:10/17/2014)... 17, 2014  Training market researchers to spot ... factor in today,s highly competitive global marketplace. As ... that effectively and efficiently produce high performing analysts, ... Effective training programs can help ... from internal clients by developing analysts who can ...
Breaking Medicine Technology:Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2
... LLC today announced the appointment of Erica L. Mann as ... business based in Morristown, NJ, USA, with operations in more ... million.  Ms. Mann also becomes a member of the Bayer ... 14, 2011. Ms. Mann most recently served as ...
... NEW YORK, Feb. 22, 2011 Reportlinker.com announces ... in its catalogue: North American ... This research covers the state ... and restraints for growth, key trends, and end-user ...
Cached Medicine Technology:Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division 2Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division 3